Fetal Bovine Serum Market Size, Share, and Growth Analysis, By Types (Charcoal Stripped, Stem Cells), By Application (Drug Discovery, Cell Culture), By End-User, By Region - Industry Forecast 2025-2032
소태아혈청 세계 시장 규모는 2023년에 7억 4,120만 달러로 평가되며, 2024년 7억 9,227만 달러에서 2032년에는 13억 5,011만 달러로 예측 기간(2025-2032년) 동안 연평균 6.9%의 CAGR로 성장할 것으로 예상됩니다.
소태아혈청 시장은 세포 및 바이오의약품 연구에 대한 투자 증가로 인해 큰 성장을 이룰 것으로 예상됩니다. 세포배양 기술의 혁신과 재생의료에 대한 수요 증가는 이 분야를 더욱 촉진할 것으로 예상됩니다. 만성질환이 확산됨에 따라 효과적인 세포 치료에 대한 필요성이 증가하면서 소태아혈청을 생산하는 기업들에게 새로운 기회를 제공할 것으로 보입니다. 그러나 공급망 문제, 대체품의 가용성, 제품 품질의 편차, 동물실험에 대한 윤리적 문제 등이 시장 도입에 걸림돌이 될 수 있습니다. 이러한 제약을 극복하는 것은 업계에서 새롭게 대두되고 있는 윤리적, 공급적 이슈를 해결하고 증가하는 수요를 충족시키려는 기업에게 매우 중요합니다.
목차
소개
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장 가정과 제한
주요 요약
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porters 분석
주요 시장 인사이트
- 핵심성공요인
- 경쟁 정도
- 주요 투자 기회
- 시장 생태계
- 시장 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 기술 분석
- 규제 분석
- 특허 분석
소태아혈청 시장 규모 : 유형별
- 시장 개요
- CS(Charcoal Stripped)
- 줄기세포
- 투석
- 불활성화
- 기타
소태아혈청 시장 규모 : 용도별
- 시장 개요
- Drug Discovery
- 세포배양
- 면역측정
- 기타
소태아혈청 시장 규모 : 최종사용자별
- 시장 개요
- 조사·학술기관
- 진단 실험실
- 의약품
- 기타
소태아혈청 시장 규모
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 상위 5개사의 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채용한 전략
- 최근의 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업 개요
- 기업 상세
- 제품 포트폴리오 분석
- 기업 부문별 점유율 분석
- 매출 전년비 비교(2022-2024년)
주요 기업 개요
- Thermo Fisher Scientific(USA)
- Merck KGaA(Germany)
- Danaher Corporation(USA)
- Corning Inc.(USA)
- Bio-Techne Corporation(USA)
- HiMedia Laboratories(India)
- PAN-Biotech(Germany)
- Bovogen Biologicals Pty Ltd(Australia)
- Atlanta Biologicals Inc.(USA)
- TCS Biosciences Ltd(UK)
- Rocky Mountain Biologicals(RMBIO)(USA)
- Biowest(Sera Scandia A/S)(France)
- ZenBio, Inc.(USA)
- Gemini Bio-Products(USA)
- Atlas Biologicals, Inc.(USA)
- Moregate Biotech(Australia)
- SeraCare Life Sciences(USA)
- Access Biologicals(USA)
- Biological Industries(Israel)
- Wisent Bioproducts(Canada)
결론과 제안
ksm
Global Fetal Bovine Serum Market size was valued at USD 741.2 million in 2023 and is poised to grow from USD 792.27 million in 2024 to USD 1350.11 million by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).
The fetal bovine serum market is set to experience significant growth driven by increasing investments in cell and biopharmaceutical research. Innovations in cell culture technologies and a rising demand for regenerative medicine are anticipated to further support this sector. As chronic diseases become more prevalent, the need for effective cell therapies will create new opportunities for companies producing fetal bovine serum. However, challenges such as supply chain issues, the availability of alternatives, variability in product quality, and ethical concerns surrounding animal testing may hinder market adoption. Navigating these constraints will be crucial for companies looking to capitalize on the expanding demand while addressing emerging ethical and supply-related challenges in the industry.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fetal Bovine Serum market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Fetal Bovine Serum Market Segments Analysis
Global Fetal Bovine Serum Market is segmented by Types, Application, End-User and region. Based on Types, the market is segmented into Charcoal Stripped, Stem Cells, Dialyzed, Inactivated and Others. Based on Application, the market is segmented into Drug Discovery, Cell Culture, Immunoassay and Others. Based on End-User, the market is segmented into Research And Academic Institutions, Diagnostics Labs, Pharmaceuticals and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Fetal Bovine Serum Market
The escalating demand for monoclonal antibodies, vaccines, and cell therapies used in the treatment of various diseases has significantly increased the need for biopharmaceutical research globally. Fetal bovine serum plays a crucial role as an essential supplement in cell culture media, which is vital for biopharmaceutical production. This growing reliance on fetal bovine serum as a fundamental component in the development and production of these therapeutic agents is driving remarkable growth in the fetal bovine serum market, positioning it as a critical factor in the advancement of innovative medical treatments worldwide.
Restraints in the Global Fetal Bovine Serum Market
The global fetal bovine serum market faces significant challenges due to ethical concerns surrounding the collection process, which involves the use of bovine fetuses. Increasing objections from animal welfare organizations and a growing public sensitivity toward animal rights are intensifying scrutiny over medical practices that utilize animal-derived products. This heightened awareness and opposition are creating a complex ethical dilemma that could potentially hinder the market's growth and future prospects. As more individuals advocate for humane alternatives to animal-based research materials, the demand for fetal bovine serum may be adversely affected, posing a substantial restraint on the market's expansion.
Market Trends of the Global Fetal Bovine Serum Market
The Global Fetal Bovine Serum (FBS) market is witnessing a significant trend towards the adoption of 3D cell culture technologies, fueled by escalating investments in biopharmaceutical research and development. As researchers increasingly recognize the advantages of 3D cell culture in mimicking in vivo conditions, the demand for high-quality FBS is surging, presenting lucrative opportunities for suppliers. FBS is crucial for sustaining the stability and viability of these intricate cellular systems, enhancing both the efficacy of research and the market potential for providers. This evolving landscape is likely to drive revenue growth and innovation within the FBS market over the coming years.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Technology Analysis
- Regulatory Analysis
- Patent Analysis
Global Fetal Bovine Serum Market Size by Types & CAGR (2025-2032)
- Market Overview
- Charcoal Stripped
- Stem Cells
- Dialyzed
- Inactivated
- Others
Global Fetal Bovine Serum Market Size by Application & CAGR (2025-2032)
- Market Overview
- Drug Discovery
- Cell Culture
- Immunoassay
- Others
Global Fetal Bovine Serum Market Size by End-User & CAGR (2025-2032)
- Market Overview
- Research And Academic Institutions
- Diagnostics Labs
- Pharmaceuticals
- Others
Global Fetal Bovine Serum Market Size & CAGR (2025-2032)
- North America (Types, Application, End-User)
- Europe (Types, Application, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Types, Application, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Types, Application, End-User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Types, Application, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Corning Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Techne Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- HiMedia Laboratories (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PAN-Biotech (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bovogen Biologicals Pty Ltd (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Atlanta Biologicals Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TCS Biosciences Ltd (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rocky Mountain Biologicals (RMBIO) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biowest (Sera Scandia A/S) (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ZenBio, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gemini Bio-Products (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Atlas Biologicals, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Moregate Biotech (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SeraCare Life Sciences (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Access Biologicals (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biological Industries (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wisent Bioproducts (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
